These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26980931)

  • 21. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
    Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery.
    Sharabi-Nov A; Kumar K; Fabjan Vodušek V; Premru Sršen T; Tul N; Fabjan T; Meiri H; Nicolaides KH; Osredkar J
    Fetal Diagn Ther; 2020; 47(6):471-484. PubMed ID: 31778996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.
    Raia-Barjat T; Prieux C; Gris JC; Chapelle C; Laporte S; Chauleur C
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):248-257. PubMed ID: 28889770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia.
    Gumus E; Atalay MA; Cetinkaya Demir B; Sahin Gunes E
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3806-11. PubMed ID: 26821682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First trimester 3D ultrasound placental volume for predicting preeclampsia and/or intrauterine growth restriction.
    Soongsatitanon A; Phupong V
    J Obstet Gynaecol; 2019 May; 39(4):474-479. PubMed ID: 30585097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia.
    Jeyabalan A; McGonigal S; Gilmour C; Hubel CA; Rajakumar A
    Placenta; 2008 Jun; 29(6):555-63. PubMed ID: 18462791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia.
    Barneo-Caragol C; Martínez-Morillo E; Rodríguez-González S; Lequerica-Fernández P; Vega-Naredo I; Álvarez FV
    Free Radic Biol Med; 2019 Jul; 138():1-9. PubMed ID: 31055131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia?
    Tokmak A; Güney G; Aksoy RT; Guzel AI; Topcu HO; Keçecioğlu TS; Uygur D
    J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1451-6. PubMed ID: 25133554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia.
    Bayhan G; Atamer Y; Atamer A; Yokus B; Baylan Y
    Clin Exp Obstet Gynecol; 2000; 27(2):142-6. PubMed ID: 10968357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
    Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A; Maciejewski T; Niemiec KT
    Med Wieku Rozwoj; 2013; 17(3):232-45. PubMed ID: 24296447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus.
    Baykus Y; Yavuzkir S; Ustebay S; Ugur K; Deniz R; Aydin S
    Peptides; 2019 Oct; 120():170132. PubMed ID: 31400492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preeclampsia with and without intrauterine growth restriction-Two pathogenetically different entities?
    Milosevic-Stevanovic J; Krstic M; Radovic-Janosevic D; Stefanovic M; Antic V; Djordjevic I
    Hypertens Pregnancy; 2016 Nov; 35(4):573-582. PubMed ID: 27624400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia.
    Oztas E; Ozler S; Ersoy AO; Iskender CT; Sucak A; Ergin M; Uygur D; Danisman N
    J Perinat Med; 2016 Apr; 44(3):269-75. PubMed ID: 26352072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal and fetal cord blood lipids in intrauterine growth restriction.
    Pecks U; Brieger M; Schiessl B; Bauerschlag DO; Piroth D; Bruno B; Fitzner C; Orlikowsky T; Maass N; Rath W
    J Perinat Med; 2012 Jan; 40(3):287-96. PubMed ID: 22505508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.